FDA approves Ironwood constipation drug

(Reuters) – The Food and Drug Administration on Thursday approved Ironwood Pharmaceuticals Inc’s drug to treat chronic constipation and irritable bowel syndrome with constipation for use in adults. The drug, linaclotide, will be sold under the brand name Linzess and carry a boxed warning that it should not be used in patients 16 or younger, the agency said. An estimated 63 million people suffer from chronic constipation, according to the National Institutes of Health. Additionally, an estimated 15. …

FDA recalls another CareFusion infusion pump

(Reuters) – U.S. health regulators announced a recall of CareFusion’s Alaris pump module Model 8100, saying a potential keypad malfunction in the infusion pump could cause serious injury or death. The U.S. Food and Drug Administration said the affected pump modules, used for delivering a variety of fluids, drugs and blood products to patients, were manufactured between October 2011 and February 2012. The FDA classified the action as a Class I recall on its website, meaning that the defective units could cause serious harm to a patient’s health. …

FDA extends review time for NPS Pharma’s bowel drug by three months

(Reuters) – NPS Pharmaceuticals Inc said U.S. health regulators pushed back the review date for the marketing approval application for its experimental bowel drug by three months. U.S. Food and Drug Administration will now decide on the approval of Gattex on December 30, 2012, the drugmaker said in a statement. The FDA extended the date to provide time for a full review of the submission, NPS Pharmaceuticals said. The application was accepted by the agency in January 2012. …

FDA approves Talon’s Marqibo for rare leukemia

WASHINGTON (Reuters) – The Food and Drug Administration said on Thursday it has approved Talon Therapeutics Inc’s Marqibo treatment for adults with a rare form of leukemia known as Philadelphia chromosome negative acute lymphoblastic leukemia. The drug, a targeted version of generic chemotherapy drug vincristine, will be the first commercial product for Talon. The company is majority-owned by Warburg Pincus and Deerfield Management, but shares accounting for a minority portion of its equity trade over-the-counter and were down 5 percent in afternoon trading. …

FDA approves Novartis drug Afinitor for breast cancer

(Reuters) – The U.S. Food and Drug Administration on Friday approved Novartis AG drug Afinitor to treat women with a certain type of breast cancer. The drug is the first in a class known as mTOR inhibitors to be approved for post-menopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. The European Medicines Agency in June also endorsed Afinitor as a breast cancer treatment. …

1 3 4 5 6 7 19